Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FGM1J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,269
Award facts
- Contract value 100% obligated
- $17,268.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,268.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL units). The contract, which is a non-set-aside competitive award, is set to be completed by December 31, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
Zepbound is a GLP-1 receptor agonist used for weight management, representing an increasingly critical pharmaceutical commodity within federal medical supply chains. AmerisourceBergen's substantial IDC with DLA Troop Support Medical enables the company to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with a broad portfolio of specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The DLA Troop Support Medical is concurrently pursuing a Pharmaceutical Prime Vendor Global Program Generation V strategy with plans for multiple regional awards, positioning AmerisourceBergen as a key provider within this modernized procurement framework for military healthcare worldwide.
Quick answers
Who was awarded contract SPE2DR26FGM1J?
SPE2DR26FGM1J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FGM1J worth?
The government has obligated $17,269 on SPE2DR26FGM1J.
Is contract SPE2DR26FGM1J an order under another contract?
Yes. SPE2DR26FGM1J is a delivery order under SPE2DR25D1002, an indefinite delivery contract.
Was contract SPE2DR26FGM1J competed?
The extent of competition for SPE2DR26FGM1J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award